Gilinsky N H, Bornman P C, Girdwood A H, Marks I N
Br J Surg. 1986 Jul;73(7):539-43. doi: 10.1002/bjs.1800730708.
The results of 117 consecutive endoscopic retrograde cholangiopancreatographic (ERCP) examinations in patients with adenocarcinoma carcinoma of the pancreas, performed over a six year period, are reported. The diagnostic accuracy of this procedure (80.3 per cent) was higher than that of computed tomography (63.6 per cent) and ultrasonography (54.0 per cent). Fewer false negative diagnoses were made by retrograde cholangiopancreatography (7.7 per cent) than with the other procedures (28 per cent each). Analysis of the total ERCP experience during the study period revealed a false positive rate for malignancy of 5.6 per cent. In situations where investigations are performed by individuals with a broad spectrum of expertise, ERCP is superior to other methods in diagnosing pancreatic carcinoma, even in areas with a high prevalence of chronic pancreatitis.
报告了在六年期间对117例胰腺癌患者连续进行内镜逆行胰胆管造影（ERCP）检查的结果。该检查的诊断准确率（80.3%）高于计算机断层扫描（63.6%）和超声检查（54.0%）。逆行胰胆管造影的假阴性诊断率（7.7%）低于其他检查（均为28%）。对研究期间ERCP总经验的分析显示，恶性肿瘤的假阳性率为5.6%。在由具有广泛专业知识的人员进行检查的情况下，即使在慢性胰腺炎高发地区，ERCP在诊断胰腺癌方面也优于其他方法。
